| OPENING KEYNOTE — KEY OPINION LEADERS — THE DEBATE, David Gillen, Medical Director, Pfizer |
 |
 |
 |
 |
 |
| REGULATION OF KOL-INDUSTRY RELATIONSHIPS, Richard Tiner, Medical Director, Association of the British Pharmaceutical Industry (ABPI) |
 |
 |
 |
 |
 |
| THE SCOTTISH APPROACH TO RAPID HEALTH TECHNOLOGY ASSESSMENT, Keith Tolley, Economics Assessor, New Drugs Committee, Scottish Medicines Consortium |
 |
 |
 |
 |
 |
| PRACTITIONERS PERSPECTIVE OF A KOL RELATIONSHIP, Iain Macdougall, Consultant Nephrologist and Honorary Senior Lecturer, King's College Hospital |
 |
 |
 |
 |
 |
| REDEFINING EXPERT RELATIONSHIPS, Sue Wright, Development Director, Adelphi Communications |
 |
 |
 |
 |
 |
| INDUSTRY PERSPECTIVE OF A KOL RELATIONSHIP — US CASE STUDY, Malcolm Allison, Head of Strategic Marketing, Actelion |
 |
 |
 |
 |
 |
| RESOLVING CONFLICTS OF INTEREST, Gerry Thompson, Marketing Director, EMEA, Stiefel Laboratories |
 |
| Presentation cancelled |
 |
 |
 |
| CAN OUR LAPTOPS SAVE US?, Sanjay Singhvi, Director, System Analytic |
 |
 |
 |
 |
 |
| IS THE USE OF KOLS REALLY A THREAT?, Tom Stossel, Professor, Harvard Medical School and Senior Fellow at Manhattan Institute for Policy Research |
 |
 |
 |
 |
 |
| THE SCIENCE OF OPINION LEADERSHIP, Aafia Chaudhry, Managing Director, 81qd |
 |
 |
 |
 |
 |
| STRATEGIC APPROACH TO A KOL PROGRAMME, Andrew Scheifele, Director, Regional Medical Liasons, Amgen |
 |
 |
 |
 |
 |
| THE CHANGING FACE OF KOL ALIGNMENTS: ARE PHARMA AND PHYSICIANS BRAVE ENOUGH TO ENGAGE EQUALLY?, Emma Parfrement, Leader, Strategic Insights, myPHID |
 |
 |
 |
 |
 |
| PANEL DISCUSSION — PROPOSING A REALISTIC CODE FOR GRP |
 |
| Debate cancelled |
 |
 |
 |
Marc Sluijs of Oracle made a presentation about customer relationship management tools.
It was not possible to prepare a summary of this presentation. |
 |
 |
 |
| HONESTY IS THE BEST POLICY, Neil Kendle, Managing Director, Kendle Healthcare |
 |
 |
 |
 |
 |
| CONCLUSION BY THE CO-CHAIRMAN |
 |
 |
 |
 |
 |
If there is a question that you would like to forward to this group of experts please let us know.


If you require Acrobat Reader to view the PDF's 'click and get Adobe Reader'. |